FDA approves Roche Ebola test for emergency use

By

Roche Holding AG said U.S. health regulators have approved its Ebola test for emergency use in response to the world's worst outbreak of the disease in West Africa.

The U.S. Food and Drug Administration (FDA) has approved Roche's LightMix Ebola Zaire rRT-PCR Test for use on patients with signs and symptoms of Ebola Zaire virus infection, the Swiss drugmaker said in a statement.

Roche said the LightMix test can generate results in just over three hours, helping to detect the virus quickly so treatment can start as soon as possible.

Under the emergency use designation, certain laboratories in the United States and other countries have been authorized to use the test for a limited period to detect the type of Ebola that has been spreading in West Africa.

The test, made by TIB MOLBIOL GmbH and distributed by Roche, has not been approved by the FDA for general use.

The global death toll from Ebola has risen to 7,588 out of 19,497 confirmed cases recorded in the year-old epidemic in West Africa, the World Health Organization said last Wednesday.

Tags
Ebola, West Africa, U.S. Food and Drug Administration, FDA
Join the Discussion
More News
Toddler Beaten to Death After Louisiana Mom Left 8 Children

Toddler Beaten to Death After Louisiana Mom Left 8 Children Alone While She Went to the Casino

Julia

Uber Refused to Help Police Find Missing Child After Driver Speeds Off With Sleeping Kid in the Car, Parents Claim

FSU Shooting

Parkland Survivors Faced Second Deadly School Shooting at FSU: 'I Kind of Knew the Drill Already'

Jammacar Rodkesh Gayle

Florida Man Steals Knife From Butcher Counter to Brutally Stab Woman Who Criticized His 'Uncontrolled' Children